Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glutathione Transferase | 12 | 2011 | 26 | 1.470 |
Why?
|
| Cytochrome P-450 CYP1A1 | 6 | 2009 | 12 | 1.400 |
Why?
|
| Glutathione S-Transferase pi | 7 | 2011 | 9 | 1.080 |
Why?
|
| Benzo(a)pyrene | 4 | 2009 | 5 | 0.850 |
Why?
|
| Dihydroxydihydrobenzopyrenes | 3 | 2009 | 3 | 0.820 |
Why?
|
| Mutagens | 3 | 2007 | 6 | 0.770 |
Why?
|
| Glutathione | 8 | 2011 | 54 | 0.710 |
Why?
|
| DNA Adducts | 3 | 2007 | 15 | 0.570 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 3 | 2007 | 3 | 0.560 |
Why?
|
| Multidrug Resistance-Associated Proteins | 6 | 2008 | 9 | 0.480 |
Why?
|
| Aldehydes | 2 | 2011 | 6 | 0.400 |
Why?
|
| Transfection | 9 | 2011 | 204 | 0.360 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 2008 | 6 | 0.350 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 2007 | 26 | 0.320 |
Why?
|
| Transgenes | 2 | 2009 | 46 | 0.310 |
Why?
|
| Naphthalenes | 1 | 2009 | 53 | 0.290 |
Why?
|
| Chrysenes | 1 | 2008 | 1 | 0.290 |
Why?
|
| Cell Line | 7 | 2008 | 454 | 0.270 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2008 | 106 | 0.270 |
Why?
|
| Benzopyrenes | 1 | 2007 | 1 | 0.260 |
Why?
|
| DNA Damage | 2 | 2006 | 90 | 0.250 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 83 | 0.250 |
Why?
|
| Carcinogens | 4 | 2008 | 36 | 0.250 |
Why?
|
| Mutagenesis | 1 | 2006 | 34 | 0.250 |
Why?
|
| Cell Line, Tumor | 10 | 2011 | 729 | 0.240 |
Why?
|
| Mitoxantrone | 1 | 2006 | 20 | 0.240 |
Why?
|
| Antineoplastic Agents | 2 | 2006 | 595 | 0.210 |
Why?
|
| Cricetinae | 4 | 2007 | 51 | 0.210 |
Why?
|
| Animals | 11 | 2011 | 8199 | 0.200 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 3 | 2008 | 3 | 0.200 |
Why?
|
| Cell Survival | 5 | 2008 | 288 | 0.200 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2011 | 26 | 0.170 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2011 | 717 | 0.160 |
Why?
|
| PPAR gamma | 2 | 2011 | 51 | 0.160 |
Why?
|
| Humans | 19 | 2011 | 32284 | 0.160 |
Why?
|
| Anticarcinogenic Agents | 2 | 2009 | 26 | 0.140 |
Why?
|
| Mutagenicity Tests | 2 | 2008 | 2 | 0.140 |
Why?
|
| Isoenzymes | 7 | 2009 | 67 | 0.130 |
Why?
|
| Cricetulus | 2 | 2007 | 21 | 0.130 |
Why?
|
| Transcriptional Activation | 3 | 2008 | 46 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2009 | 839 | 0.120 |
Why?
|
| Prostaglandin D2 | 2 | 2004 | 5 | 0.100 |
Why?
|
| Alkenes | 2 | 2011 | 4 | 0.100 |
Why?
|
| Liver | 2 | 2006 | 492 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2011 | 140 | 0.090 |
Why?
|
| Rats | 2 | 2009 | 1895 | 0.090 |
Why?
|
| Nitrogen Oxides | 1 | 2011 | 6 | 0.090 |
Why?
|
| Linoleic Acids | 1 | 2011 | 4 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 42 | 0.090 |
Why?
|
| Response Elements | 1 | 2011 | 16 | 0.090 |
Why?
|
| Oleic Acids | 1 | 2011 | 9 | 0.090 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2011 | 12 | 0.090 |
Why?
|
| Iron | 1 | 2011 | 94 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2011 | 121 | 0.080 |
Why?
|
| Propionates | 2 | 2011 | 8 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2011 | 603 | 0.080 |
Why?
|
| Quinolines | 2 | 2011 | 29 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 264 | 0.080 |
Why?
|
| Biological Transport | 5 | 2011 | 75 | 0.080 |
Why?
|
| Fibroblasts | 2 | 2007 | 119 | 0.080 |
Why?
|
| Nitro Compounds | 1 | 2009 | 3 | 0.080 |
Why?
|
| Curcumin | 1 | 2009 | 8 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2009 | 70 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2009 | 60 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2009 | 100 | 0.070 |
Why?
|
| Adenosine Triphosphate | 2 | 2006 | 71 | 0.070 |
Why?
|
| Cisplatin | 1 | 2008 | 78 | 0.070 |
Why?
|
| Thiocyanates | 1 | 2008 | 3 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2011 | 727 | 0.070 |
Why?
|
| Stereoisomerism | 1 | 2007 | 26 | 0.070 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2004 | 15 | 0.060 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2005 | 45 | 0.060 |
Why?
|
| Alkylation | 1 | 2006 | 7 | 0.060 |
Why?
|
| Methylene Chloride | 1 | 2006 | 1 | 0.060 |
Why?
|
| Cross-Linking Reagents | 1 | 2006 | 17 | 0.060 |
Why?
|
| Methylcholanthrene | 1 | 2006 | 7 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2011 | 478 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2003 | 138 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2004 | 183 | 0.060 |
Why?
|
| DNA | 1 | 2007 | 223 | 0.060 |
Why?
|
| Prodrugs | 1 | 2005 | 17 | 0.060 |
Why?
|
| 4-Nitroquinoline-1-oxide | 1 | 2005 | 2 | 0.060 |
Why?
|
| Thermodynamics | 1 | 2005 | 57 | 0.060 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 423 | 0.060 |
Why?
|
| Kinetics | 4 | 2009 | 250 | 0.060 |
Why?
|
| Mutation | 1 | 2007 | 497 | 0.050 |
Why?
|
| Breast Neoplasms | 3 | 2009 | 762 | 0.050 |
Why?
|
| Lung | 1 | 2006 | 263 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2004 | 43 | 0.050 |
Why?
|
| Chlorambucil | 1 | 2003 | 1 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2003 | 39 | 0.050 |
Why?
|
| Cyclic S-Oxides | 1 | 2003 | 1 | 0.050 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2003 | 8 | 0.050 |
Why?
|
| Heterocyclic Compounds, 1-Ring | 1 | 2003 | 6 | 0.050 |
Why?
|
| Cornea | 1 | 2003 | 16 | 0.050 |
Why?
|
| Ferritins | 1 | 2003 | 38 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2003 | 48 | 0.050 |
Why?
|
| Immunologic Factors | 1 | 2003 | 53 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2003 | 132 | 0.050 |
Why?
|
| Catalysis | 3 | 2008 | 71 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2003 | 499 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2003 | 255 | 0.040 |
Why?
|
| Mice | 3 | 2011 | 2571 | 0.040 |
Why?
|
| Neoplasms | 1 | 2005 | 754 | 0.030 |
Why?
|
| Transduction, Genetic | 2 | 2008 | 39 | 0.030 |
Why?
|
| Cell Death | 2 | 2008 | 79 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2008 | 258 | 0.030 |
Why?
|
| Genetic Vectors | 2 | 2005 | 108 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 164 | 0.020 |
Why?
|
| S-Nitrosoglutathione | 1 | 2011 | 5 | 0.020 |
Why?
|
| Intracellular Space | 1 | 2011 | 17 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2011 | 20 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2011 | 30 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 3 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 79 | 0.020 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2009 | 20 | 0.020 |
Why?
|
| Solubility | 1 | 2009 | 39 | 0.020 |
Why?
|
| Butylated Hydroxytoluene | 1 | 2009 | 2 | 0.020 |
Why?
|
| Sulindac | 1 | 2009 | 2 | 0.020 |
Why?
|
| Genes, ras | 1 | 2009 | 26 | 0.020 |
Why?
|
| Doxycycline | 1 | 2009 | 26 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 80 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 15 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 257 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2008 | 65 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2009 | 163 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 98 | 0.020 |
Why?
|
| Alleles | 1 | 2008 | 250 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2008 | 41 | 0.020 |
Why?
|
| Isothiocyanates | 1 | 2008 | 14 | 0.020 |
Why?
|
| Comet Assay | 1 | 2006 | 3 | 0.020 |
Why?
|
| Formaldehyde | 1 | 2006 | 15 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2006 | 21 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2006 | 11 | 0.020 |
Why?
|
| Female | 3 | 2009 | 19947 | 0.010 |
Why?
|
| Species Specificity | 1 | 2006 | 98 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 196 | 0.010 |
Why?
|
| Transport Vesicles | 1 | 2005 | 2 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2005 | 69 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2005 | 80 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 58 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2005 | 69 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2005 | 76 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 556 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 274 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 2004 | 7 | 0.010 |
Why?
|
| Chemokines, CC | 1 | 2003 | 6 | 0.010 |
Why?
|
| Cell Division | 1 | 2003 | 92 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2003 | 56 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 792 | 0.010 |
Why?
|
| NADP | 1 | 2003 | 12 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2003 | 11 | 0.010 |
Why?
|
| Luciferases | 1 | 2003 | 33 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 41 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2003 | 38 | 0.010 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 34 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2003 | 87 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2003 | 93 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 109 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 961 | 0.010 |
Why?
|
| Methotrexate | 1 | 2003 | 70 | 0.010 |
Why?
|
| Apoptosis | 1 | 2003 | 375 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 2205 | 0.010 |
Why?
|
| Male | 1 | 2006 | 19443 | 0.000 |
Why?
|